← All stocks

Serina Therapeutics, Inc.

SER Net buying
CIK 0001708599 #4575 in the set updated 18 Sep 2026
Bought (12 mo)
$77.93K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$501.44K
$0.00 on a plan · $501.44K straight out of an exercise
Sold at will
$0.00
0 of 29 sales
Net
−$423.51K
+$77.93K against sales at will

By person

8 insiders · 39 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Moreadith Randall
Chief Scientific Officer
$501.44K (29) scheduled
−$501.44K
0
$0.00
WILSON KAREN J
Director
$54.75K (4)
+$54.75K
10,100
$20.50K
Marshall Richard Peter
Director
$20.10K (1)
+$20.10K
12,183
$24.73K
Brannan Stephen K.
Director
$2.03K (1)
+$2.03K
1,000
$2.03K
Venkatesan Jay
Director
$1.05K (1)
+$1.05K
232,294
$471.56K
Bailey Gregory
Director
8,564,382
$17.39M
+17,798%
Juvenescence Ltd entity
10% owner
3,267,188
$6.63M
+44.1%
LEDGER STEVEN A
Chief Executive Officer
10,100
$20.50K

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 8,891,976 to 25,400,473 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 51
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 29
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 8,892,770
History held since 12 Dec 2018